Basic mechanisms of androgen-independent growth in the prostate cancer
Komiya, A.; Yasuda, K.; Watanabe, A.; Fuse, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 5): 96-103
2011
ISSN/ISBN: 0047-1852 PMID: 22207950 Document Number: 648540
Document emailed within 1 workday
Related Documents
Xu, K.; Wang, X.; Ling, M.; Wong, Y. 2003: Growth inhibiting effects of terazosin on androgen-independent prostate cancer cell lines Chinese Medical Journal 116(11): 1673-1677Amler, L.C.; Agus, D.B.; LeDuc, C.; Sapinoso, M.L.; Fox, W.D.; Kern, S.; Lee, D.; Wang, V.; Leysens, M.; Higgins, B.; Martin, J.; Gerald, W.; Dracopoli, N.; Cordon-Cardo, C.; Scher, H.I.; Hampton, G.M. 2000: Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1 Cancer Research 60(21): 6134-6141
Roth, B.J. 1999: Androgen-independent prostate cancer: not so chemorefractory after all Seminars in Oncology 26(6 Suppl 18: 43-50
Guan, X-xiang.; Chen, L-bang. 2006: Current opinions on the treatment of androgen-independent prostate cancer Zhonghua Nan Ke Xue 12(11): 1021-1025
Zhou, P.; Lin, Y.-r.; Huang, M.-p.; Xie, K.-j.; Tang, P. 2013: 2-deoxyglucose enhances chemosensitivity of androgen-independent prostate cancer cells to docetaxel Zhonghua Yi Xue Za Zhi 93(40): 3230-3234
Copeland, R.L.; Das, J.R.; Bakare, O.; Enwerem, N.M.; Berhe, S.; Hillaire, K.; White, D.; Beyene, D.; Kassim, O.O.; Kanaan, Y.M. 2007: Cytotoxicity of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone in androgen-dependent and -independent prostate cancer cell lines Anticancer Research 27(3b): 1537-1546
Van Steenbrugge, G.J.; Groen, M.; Bolt-de Vries, J.; Romijn, J.C.; Schroeder, F.H. 1985: Human prostate cancer (PC-82) in nude mice: a model to study androgen regulated tumor growth Progress in Clinical and Biological Research 185a: 23-50
Pettaway, C.A. 1999: Racial differences in the androgen/androgen receptor pathway in prostate cancer Journal of the National Medical Association 91(12): 653-660
Bastos, D.A.; Dzik, C.; Rathkopf, D.; Scher, H.I. 2014: Expanding androgen- and androgen receptor signaling-directed therapies for castration-resistant prostate cancer Oncology 28(8): 693-699
Izbicka, E.; MacDonald, J.R.; Davidson, K.; Lawrence, R.A.; Gomez, L.; Von Hoff, D.D. 1999: 5,6 Dihydro-5'-azacytidine (DHAC) restores androgen responsiveness in androgen-insensitive prostate cancer cells Anticancer Research 19(2a): 1285-1291
Koivisto, P.; Kononen, J.; Palmberg, C.; Tammela, T.; Hyytinen, E.; Isola, J.; Trapman, J.; Cleutjens, K.; Noordzij, A.; Visakorpi, T.; Kallioniemi, O.P. 1997: Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer Cancer Research 57(2): 314-319
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Dondi, D.; Limonta, P.; Moretti, R.M.; Marelli, M.M.; Garattini, E.; Motta, M. 1994: Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop Cancer Research 54(15): 4091-4095
Lee, I.; Lee, Y.H.; Mikulski, S.M.; Lee, J.; Shogen, K. 2000: Enhanced cellular radiation sensitivity of androgen-independent human prostate tumor cells by onconase Anticancer Research 20(2a): 1037-1040
Gao, J.; Isaacs, J.T. 1998: Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells Cancer Research 58(15): 3299-3306
Jarrard, D.F.; Kinoshita, H.; Shi, Y.; Sandefur, C.; Hoff, D.; Meisner, L.F.; Chang, C.; Herman, J.G.; Isaacs, W.B.; Nassif, N. 1998: Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells Cancer Research 58(23): 5310-5314
Olapade-Olaopa, E.O.; Moscatello, D.K.; MacKay, E.H.; Sandhu, D.P.S.; Terry, T.R.; Wong, A.J.; Habib, F.K. 2004: Alterations in the expression of androgen receptor, wild type-epidermal growth factor receptor and a mutant epidermal growth factor receptor in human prostate cancer African Journal of Medicine and Medical Sciences 33(3): 245-253
Müntzing, J. 1988: Regulation of prostatic growth. Growth-limiting mechanisms in the rat ventral prostate Scandinavian Journal of Urology and Nephrology. Supplementum 107: 52-55
Kagebayashi, Y.; Ozono, S.; Takashima, K.; Yoshikawa, M.; Hayashi, Y.; Kaneko, Y.; Maruyama, Y.; Hirao, Y.; Okajima, E. 1997: Total androgen blockade for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 43(3): 197-201
Mizokami, A.; Izumi, K.; Namiki, M. 2016: Role of adrenal androgen in prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 99-105